BioFlo 44022Recalls & reported problems
Navilyst Medical, Inc. · BioFlo Plastic Port with PASV Valve Technology (Filled Suture Holes) and 8F x 63cm Polyurethane Catheter with ENDEXO Technology · Class 2 · Implant
All models of BioFlo (87)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI H965440220), received between Sep 26, 2017 and Oct 21, 2024 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Aspiration Issue” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Aspiration Issue1
- Device Contamination with Chemical or Other Material1
- Infusion or Flow Problem1
Patient problems
- No Known Impact Or Consequence To Patient2
- Unspecified Infection1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryOct 21, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2019, (B)(6) UNDERWENT PLACEMENT OF AN ANGIODYNAMICS BIOFLO PRODUCT, MODEL #/MFG CAT ID: H965440220, LOT NUMBER 5482424. UPON INFORMATION AND BELIEF, THE DEVICE AT ISSUE WAS IMPLANTED BY DR. (B)(6), M.D., AT (B)(6), FOR CHEMOTHERAPY TREATMENT FOR PLAINTIFF'S GLIOBLASTOMA MULTIFORME. ON OR ABOUT (B)(6) 2021, PLAINTIFF PRESENTED TO (B)(6) MEDICAL CENTER IN (B)(6), WITH A BLOCKED PORT-A CATH, WHICH PROMPTED EVALUATION OF HIS CATHETER. UPON INFORMATION AND BELIEF, ON (B)(6) 2021, THE PLAINTIFF'S MEDICAL TEAM DETERMINED THAT PLAINTIFF HAD A PORT-A-CATH INFECTION. THE PLAINTIFF MEDICAL TEAM THEN DECIDED TO ARRANGE FOR PLAINTIFF'S PORT REMOVAL THROUGH INTERVENTIONAL RADIOLOGY. ON (B)(6) 2021, (B)(6) PRESENTED TO THE OPERATING ROOM AT (B)(6) MEDICAL CENTER. UPON INFORMATION AND BELIEF, THE INFECTED PORT WAS THEN REMOVED BY DR. (B)(6), MD, AN INTERVENTIONAL RADIOLOGIST.
Patient problems: Unspecified Infection
MAUDE report 20493326 ↗MalfunctionJan 15, 2018Aspiration Issue; Aspiration Issue
AS REPORTED, BIOFLO PORT PLACED ON (B)(6) 2017 WAS REMOVED ON (B)(6) 2017 BECAUSE OF FIBRIN SHEATH FORMATION NEAR THE TIP OF THE CATHETER CAUSING OCCLUSION. THERE WAS NO INJURY INCURRED BY THE PATIENT. THE USED DEVICE WILL NOT BE RETURNED TO ANGIODYNAMICS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7191469 ↗MalfunctionSep 26, 2017Device Contamination with Chemical or Other Material; Infusion or Flow Problem; Device Contamination with Chemical or Other Material; Infusion or Flow Problem
ON (B)(6) 2017 THE PATIENT HAD A BIOFLO PORT IMPLANTED. UPON COMPLETING SURGERY, THE MD WAS UNABLE TO ASPIRATE THE PORT. WITH THE PATIENT STILL ON THE TABLE, THE PHYSICIAN REMOVED THE PORT AND INSERTED A NEW PORT, USING SAME CATHETER. ABLE TO DRAW BLOOD AND INFUSE. A JELLY-LIKE SUBSTANCE WAS REPORTED TO BE FOUND IN THE PORT CHAMBER. THERE WAS NO IMPACT ON THE PATIENT. THE ORIGINAL PORT HAS BEEN RETURNED TO ANGIODYNAMICS FOR EVALUATION.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6893322 ↗
Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices
- PowerPort M.R.I., Groshong 9808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR3 deaths834 reports
- PowerPort ClearVUE 1608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR18 deaths571 reports
- PowerPort ClearVUE 5608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR31 deaths542 reports
- PowerPort M.R.I., ChronoFlex 1808000Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR19 deaths513 reports
- PowerPort M.R.I., ChronoFlex 1808060Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR1 recall15 deaths383 reports
- PowerPort M.R.I., Groshong 1808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR10 deaths304 reports
- PowerPort M.R.I., ChronoFlex 1829500Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR6 deaths197 reports
- BardPort M.R.I. 0602680Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR2 deaths179 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page